RadioMedix is a biotechnology company focused on providing targeted radiopharmaceuticals for diagnosis, monitoring, and therapy of cancer. It commercializes products for PET (positron emission tomography) imaging and targeted alpha and beta-emitter therapy. The company offers SmartMedix, an automated laboratory system for the synthesis of PET tracers for the research and clinical markets.